ABCC10 and colorectal carcinoma: Only one analysis based on an investigation of 1444 SNPs from a cohort of 623 stage II-IV CRC patients pointed out that 6 transporter genes, ABCC10 included, could be predictive to identify the patients who were more likely to benefit from Oxaliplatin treatment [20].